{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:49:33Z","timestamp":1767923373060,"version":"3.49.0"},"reference-count":204,"publisher":"Harborside Press, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:p>Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed\/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.<\/jats:p>","DOI":"10.6004\/jnccn.2020.0036","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T19:25:28Z","timestamp":1596655528000},"page":"1105-1123","source":"Crossref","is-referenced-by-count":8,"title":["Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology"],"prefix":"10.6004","volume":"18","author":[{"given":"Kimberly","family":"Davies","sequence":"first","affiliation":[{"name":"1Dana-Farber\/Boston Children's Cancer and Blood Disorders Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Barth","sequence":"additional","affiliation":[{"name":"2Roswell Park Comprehensive Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saro","family":"Armenian","sequence":"additional","affiliation":[{"name":"3City of Hope National Medical Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony N.","family":"Audino","sequence":"additional","affiliation":[{"name":"4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Barnette","sequence":"additional","affiliation":[{"name":"5Huntsman Cancer Institute at the University of Utah;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branko","family":"Cuglievan","sequence":"additional","affiliation":[{"name":"6The University of Texas MD Anderson Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilda","family":"Ding","sequence":"additional","affiliation":[{"name":"7UCSD Rady Children's Hospital\/UC San Diego Moores Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Ford","sequence":"additional","affiliation":[{"name":"8Fred & Pamela Buffett Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Galardy","sequence":"additional","affiliation":[{"name":"9Mayo Clinic Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Gardner","sequence":"additional","affiliation":[{"name":"10Fred Hutchinson Cancer Research Center\/Seattle Cancer Care Alliance;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabi","family":"Hanna","sequence":"additional","affiliation":[{"name":"11Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hayashi","sequence":"additional","affiliation":[{"name":"12Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra E.","family":"Kovach","sequence":"additional","affiliation":[{"name":"13Vanderbilt-Ingram Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Judit","family":"Machnitz","sequence":"additional","affiliation":[{"name":"14The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly W.","family":"Maloney","sequence":"additional","affiliation":[{"name":"15Children's Hospital of Colorado\/University of Colorado Cancer Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianna","family":"Marks","sequence":"additional","affiliation":[{"name":"16Stanford Cancer Institute;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Page","sequence":"additional","affiliation":[{"name":"17Duke Cancer Institute;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne F.","family":"Reilly","sequence":"additional","affiliation":[{"name":"18Abramson Cancer Center at the University of Pennsylvania;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna L.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"19Robert H. Lurie Comprehensive Cancer Center of Northwestern University;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Xavier","sequence":"additional","affiliation":[{"name":"20Children's of Alabama\/O'Neal Comprehensive Cancer Center at UAB; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole R.","family":"McMillian","sequence":"additional","affiliation":[{"name":"21National Comprehensive Cancer Network"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Freedman-Cass","sequence":"additional","affiliation":[{"name":"21National Comprehensive Cancer Network"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","reference":[{"key":"ref611","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jnci.2016.03.003","article-title":"Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin\u2019s lymphoma. CCHE experience","volume":"28","author":"Abdel Rahman","year":"2016","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.13040","article-title":"Rituximab with chemotherapy in children and adolescents with central nervous system and\/or bone marrow-positive Burkitt lymphoma\/leukaemia: a Children\u2019s Oncology Group Report","volume":"167","author":"Goldman","year":"2014","journal-title":"Br J Haematol"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1440-1827.2008.02295.x","article-title":"Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection","volume":"58","author":"Nomura","year":"2008","journal-title":"Pathol Int"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/bjh.15491","article-title":"Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB\/LMB 96: A report from the FAB\/LMB 96 study group","volume":"182","author":"Cairo","year":"2018","journal-title":"Br J Haematol"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bjh.13219","article-title":"The role of FDG-PET\/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma","volume":"168","author":"Bhojwani","year":"2015","journal-title":"Br J Haematol"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MNM.0b013e328334fc14","article-title":"False-positive F-18 FDG uptake in PET\/CT studies in pediatric patients with abdominal Burkitt\u2019s lymphoma","volume":"31","author":"Riad","year":"2010","journal-title":"Nucl Med Commun"},{"key":"ref1371","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","article-title":"Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement","volume":"28","author":"Pienkowska-Grela","year":"2011","journal-title":"Med Oncol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MPH.0b013e31829d4900","article-title":"Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study","volume":"36","author":"Samochatova","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref1501","author":"Genentech, Inc","year":"2019","journal-title":"RITUXAN\u00ae (rituximab) injection, for intravenous use"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"ref1991","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.cmi.2018.02.003","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)","volume":"24","author":"Mikulska","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/pbc.24722","article-title":"Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation","volume":"60","author":"Giulino-Roth","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.rcl.2016.03.004","article-title":"Pediatric extranodal lymphoma","volume":"54","author":"Chung","year":"2016","journal-title":"Radiol Clin North Am"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","article-title":"Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum","volume":"2016","author":"Sandlund","year":"2016","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"ref1411","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/annonc\/11.suppl_1.S35","article-title":"Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons","volume":"11","author":"Hutchison","year":"2000","journal-title":"Ann Oncol"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.13040","article-title":"Rituximab with chemotherapy in children and adolescents with central nervous system and\/or bone marrow-positive Burkitt lymphoma\/leukaemia: a Children\u2019s Oncology Group Report","volume":"167","author":"Goldman","year":"2014","journal-title":"Br J Haematol"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","article-title":"Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin\u2019s lymphoma: results of the FAB\/LMB 96 international study","volume":"141","author":"Gerrard","year":"2008","journal-title":"Br J Haematol"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3109\/10428194.2011.602772","article-title":"Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients","volume":"52","author":"Lu","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"ref1641","first-page":"54","article-title":"Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy","volume":"1","author":"Bailly","year":"2014","journal-title":"Front Med (Lausanne)"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbmt.2009.09.021","article-title":"Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents","volume":"16","author":"Gross","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/0366-6999.151106","article-title":"Clinicopathological study of sporadic Burkitt lymphoma in children","volume":"128","author":"Huang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","article-title":"Report on the first international workshop on interim-PET-scan in lymphoma","volume":"50","author":"Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"ref141","article-title":"Diffuse Large B-Cell Lymphoma, NOS","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","volume":"Vol. 2","author":"Swerdlow","year":"2017"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/pbc.21585","article-title":"The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: a retrospective analysis of enrolled cases in Japan","volume":"51","author":"Fujita","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"ref1541","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.cmi.2018.02.003","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)","volume":"24","author":"Mikulska","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"ref1441","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1200\/JCO.2007.11.0700","article-title":"Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin\u2019s lymphoma differ by non-Hodgkin\u2019s lymphoma subtype: a Berlin-Frankfurt-Munster Group Report","volume":"25","author":"Salzburg","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref1511","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","article-title":"Treatment of children and young adults with early-stage non-Hodgkin\u2019s lymphoma","volume":"337","author":"Link","year":"1997","journal-title":"N Engl J Med"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1002\/cncr.27396","article-title":"Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab","volume":"118","author":"Akyurek","year":"2012","journal-title":"Cancer"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1470-2045(08)70175-X","article-title":"Part I: Cancer in Indigenous Africans--burden, distribution, and trends","volume":"9","author":"Parkin","year":"2008","journal-title":"Lancet Oncol"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/pbc.26105","article-title":"Relapsed\/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: a report from the Japanese Pediatric Leukemia\/Lymphoma Study Group","volume":"63","author":"Osumi","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00259-009-1276-9","article-title":"Role of PET\/CT in malignant pediatric lymphoma","volume":"37","author":"Riad","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s12098-013-1128-2","article-title":"Pediatric lymphoma diagnosis: role of FNAC, biopsy, immunohistochemistry and molecular diagnostics","volume":"80","author":"Iyer","year":"2013","journal-title":"Indian J Pediatr"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12325-011-0041-1","article-title":"Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel","volume":"28","author":"Pession","year":"2011","journal-title":"Adv Ther"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000332","article-title":"Epstein-Barr virus (EBV)-positive sporadic burkitt lymphoma: an age-related lymphoproliferative disorder?","volume":"39","author":"Satou","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"ref1681","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","article-title":"18F-FDG PET and PET\/CT in Burkitt\u2019s lymphoma","volume":"75","author":"Karantanis","year":"2010","journal-title":"Eur J Radiol"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjh.14812","article-title":"Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents","volume":"179","author":"Szczepanowski","year":"2017","journal-title":"Br J Haematol"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3324\/haematol.2017.176107","article-title":"Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"102","author":"Lee","year":"2017","journal-title":"Haematologica"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.12542","article-title":"Rasburicase in the prevention of laboratory\/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children\u2019s Oncology Group Report","volume":"163","author":"Galardy","year":"2013","journal-title":"Br J Haematol"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","article-title":"Revised international pediatric non-Hodgkin lymphoma staging system","volume":"33","author":"Rosolen","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/QCO.0b013e328349ac4f","article-title":"The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma","volume":"24","author":"Moormann","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000332","article-title":"Epstein-Barr virus (EBV)-positive sporadic burkitt lymphoma: an age-related lymphoproliferative disorder?","volume":"39","author":"Satou","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"e27752","DOI":"10.1002\/pbc.27752","article-title":"Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe","volume":"66","author":"Vaillant","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"ref1671","first-page":"148","article-title":"Interim PET response criteria in paediatric non-Hodgkin\u2019s lymphoma. Results from a retrospective multicenter reading","volume":"52","author":"Furth","year":"2013","journal-title":"Nucl Med (Stuttg)"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3324\/haematol.2015.141119","article-title":"How to select the best available related or unrelated donor of hematopoietic stem cells?","volume":"101","author":"Tiercy","year":"2016","journal-title":"Haematologica"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"e7089","DOI":"10.1371\/journal.pone.0007089","article-title":"High resolution genome-wide analysis of chromosomal alterations in Burkitt\u2019s lymphoma","volume":"4","author":"Toujani","year":"2009","journal-title":"PLoS One"},{"key":"ref1821","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/MPH.0b013e3181fd6c79","article-title":"High-dose busulfan and cyclophosphamide as a conditioning regimen for autologous peripheral blood stem cell transplantation in childhood non-Hodgkin lymphoma patients: a long-term follow-up study","volume":"33","author":"Andion","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref2021","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jpedsurg.2012.12.002","article-title":"Intestinal perforation after treatment of Burkitt\u2019s lymphoma: case report and review of the literature","volume":"48","author":"Fallon","year":"2013","journal-title":"J Pediatr Surg"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bjh.12343","article-title":"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: study of 39 cases","volume":"162","author":"Perry","year":"2013","journal-title":"Br J Haematol"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jpedsurg.2012.12.002","article-title":"Intestinal perforation after treatment of Burkitt\u2019s lymphoma: case report and review of the literature","volume":"48","author":"Fallon","year":"2013","journal-title":"J Pediatr Surg"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2008.005355","article-title":"Clinicopathological features of lymphoma\/leukemia patients carrying both BCL2 and MYC translocations","volume":"94","author":"Tomita","year":"2009","journal-title":"Haematologica"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1200\/JCO.2014.59.0745","article-title":"International pediatric non-Hodgkin lymphoma response criteria","volume":"33","author":"Sandlund","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bjh.15520","article-title":"Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB\/LMB96 and COG ANHL01P1","volume":"185","author":"Frazer","year":"2019","journal-title":"Br J Haematol"},{"key":"ref1141","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.rcl.2016.03.004","article-title":"Pediatric extranodal lymphoma","volume":"54","author":"Chung","year":"2016","journal-title":"Radiol Clin North Am"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4143\/crt.2013.047","article-title":"Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents","volume":"46","author":"Kim","year":"2014","journal-title":"Cancer Res Treat"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s12098-013-1128-2","article-title":"Pediatric lymphoma diagnosis: role of FNAC, biopsy, immunohistochemistry and molecular diagnostics","volume":"80","author":"Iyer","year":"2013","journal-title":"Indian J Pediatr"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00043426-200403000-00006","article-title":"Chromosome abnormalities may correlate with prognosis in Burkitt\/Burkitt-like lymphomas of children and adolescents: a report from Children\u2019s Cancer Group Study CCG-E08","volume":"26","author":"Lones","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00043426-200403000-00006","article-title":"Chromosome abnormalities may correlate with prognosis in Burkitt\/Burkitt-like lymphomas of children and adolescents: a report from Children\u2019s Cancer Group Study CCG-E08","volume":"26","author":"Lones","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/pbc.25955","article-title":"Guideline for the treatment of breakthrough and the prevention of refractory chemotherapy-induced nausea and vomiting in children with cancer","volume":"63","author":"Flank","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"ref1181","article-title":"Diffuse Large B-Cell Lymphoma, NOS","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","volume":"Vol. 2","author":"Swerdlow","year":"2017"},{"key":"ref1101","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2017-11-817601","article-title":"Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma","volume":"131","author":"Ren","year":"2018","journal-title":"Blood"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3109\/10428194.2011.602772","article-title":"Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients","volume":"52","author":"Lu","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"ref1581","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-M\u00fcnster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","article-title":"Report on the first international workshop on interim-PET-scan in lymphoma","volume":"50","author":"Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3324\/haematol.2014.121434","article-title":"Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective \u201cLymphomes Malins B\u201d protocols. A Soci\u00e9t\u00e9 Fran\u00e7aise des Cancers de l\u2019Enfant study","volume":"100","author":"Jourdain","year":"2015","journal-title":"Haematologica"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00259-009-1276-9","article-title":"Role of PET\/CT in malignant pediatric lymphoma","volume":"37","author":"Riad","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref1801","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/pbc.26105","article-title":"Relapsed\/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: a report from the Japanese Pediatric Leukemia\/Lymphoma Study Group","volume":"63","author":"Osumi","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08880018.2013.834400","article-title":"Pediatric Burkitt\u2019s lymphoma and diffuse B-cell lymphoma: are surveillance scans required?","volume":"31","author":"Eissa","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"ref601","first-page":"54","article-title":"Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy","volume":"1","author":"Bailly","year":"2014","journal-title":"Front Med (Lausanne)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.beha.2018.07.013","article-title":"Burkitt lymphoma- a rare but challenging lymphoma","volume":"31","author":"Casulo","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"e27873","DOI":"10.1002\/pbc.27873","article-title":"Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study","volume":"66","author":"Rigaud","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cjp2.10","article-title":"The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit","volume":"1","author":"Clipson","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/0366-6999.151106","article-title":"Clinicopathological study of sporadic Burkitt lymphoma in children","volume":"128","author":"Huang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jnci.2016.03.003","article-title":"Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin\u2019s lymphoma. CCHE experience","volume":"28","author":"Abdel Rahman","year":"2016","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1008027","DOI":"10.1371\/journal.pgen.1008027","article-title":"Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the \u201cendemic Burkitt Lymphoma belt","volume":"15","author":"Gouveia","year":"2019","journal-title":"PLoS Genet"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/bloodadvances.2018026203","article-title":"Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients","volume":"3","author":"Naik","year":"2019","journal-title":"Blood Adv"},{"key":"ref1841","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3324\/haematol.2015.141119","article-title":"How to select the best available related or unrelated donor of hematopoietic stem cells?","volume":"101","author":"Tiercy","year":"2016","journal-title":"Haematologica"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S2352-4642(18)30059-2","article-title":"Management of fatigue in children and adolescents with cancer and in paediatric recipients of haemopoietic stem-cell transplants: a clinical practice guideline","volume":"2","author":"Robinson","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"ref131","article-title":"Burkitt Lymphoma","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","volume":"Vol. 2","author":"Swerdlow","year":"2017"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bjh.12343","article-title":"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: study of 39 cases","volume":"162","author":"Perry","year":"2013","journal-title":"Br J Haematol"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3324\/haematol.2014.121434","article-title":"Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective \u201cLymphomes Malins B\u201d protocols. A Soci\u00e9t\u00e9 Fran\u00e7aise des Cancers de l\u2019Enfant study","volume":"100","author":"Jourdain","year":"2015","journal-title":"Haematologica"},{"key":"ref1911","article-title":"Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update [published online April 28, 2017]","author":"Patel","journal-title":"Pediatr Blood Cancer"},{"key":"ref1961","doi-asserted-by":"crossref","first-page":"S632","DOI":"10.1002\/pbc.25761","article-title":"Standards of psychosocial care for parents of children with cancer","volume":"62","author":"Kearney","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"ref91","article-title":"National of Key Indicators Available at http www nlm nih gov bsd bsd key html Accessed November","volume":"14","author":"MEDLINE","year":"2019","journal-title":"Library Medicine"},{"key":"ref1791","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pbc.21753","article-title":"A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent\/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"52","author":"Griffin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmjspcare-2014-000804","article-title":"Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation","volume":"7","author":"Sung","year":"2017","journal-title":"BMJ Support Palliat Care"},{"key":"ref1851","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3324\/haematol.2017.176107","article-title":"Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"102","author":"Lee","year":"2017","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","article-title":"Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum","volume":"2016","author":"Sandlund","year":"2016","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bjh.15520","article-title":"Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB\/LMB96 and COG ANHL01P1","volume":"185","author":"Frazer","year":"2019","journal-title":"Br J Haematol"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"S632","DOI":"10.1002\/pbc.25761","article-title":"Standards of psychosocial care for parents of children with cancer","volume":"62","author":"Kearney","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/gcc.22161","article-title":"Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples","volume":"53","author":"Maria Murga Penas","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"ref2001","doi-asserted-by":"crossref","first-page":"e184169","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open"},{"key":"ref421","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol"},{"key":"ref1611","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.2009.26.6791","article-title":"Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin\u2019s lymphoma and Burkitt leukemia","volume":"28","author":"Meinhardt","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/annonc\/11.suppl_1.S35","article-title":"Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons","volume":"11","author":"Hutchison","year":"2000","journal-title":"Ann Oncol"},{"key":"ref1861","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jamaoncol.2017.0368","article-title":"Patients\u2019 and parents\u2019 needs, attitudes, and perceptions about early palliative care integration in pediatric oncology","volume":"3","author":"Levine","year":"2017","journal-title":"JAMA Oncol"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/MPH.0b013e3181fd6c79","article-title":"High-dose busulfan and cyclophosphamide as a conditioning regimen for autologous peripheral blood stem cell transplantation in childhood non-Hodgkin lymphoma patients: a long-term follow-up study","volume":"33","author":"Andion","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref871","article-title":"Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update [published online April 28, 2017]","author":"Patel","journal-title":"Pediatr Blood Cancer"},{"key":"ref1621","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MPH.0b013e31829d4900","article-title":"Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study","volume":"36","author":"Samochatova","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","article-title":"18F-FDG PET and PET\/CT in Burkitt\u2019s lymphoma","volume":"75","author":"Karantanis","year":"2010","journal-title":"Eur J Radiol"},{"key":"ref1921","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmjspcare-2014-000804","article-title":"Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation","volume":"7","author":"Sung","year":"2017","journal-title":"BMJ Support Palliat Care"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1440-1827.2008.02295.x","article-title":"Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection","volume":"58","author":"Nomura","year":"2008","journal-title":"Pathol Int"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1470-2045(08)70175-X","article-title":"Part I: Cancer in Indigenous Africans--burden, distribution, and trends","volume":"9","author":"Parkin","year":"2008","journal-title":"Lancet Oncol"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.2009.26.6791","article-title":"Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin\u2019s lymphoma and Burkitt leukemia","volume":"28","author":"Meinhardt","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref1131","article-title":"National of Key Indicators Available at http www nlm nih gov bsd bsd key html Accessed November","volume":"14","author":"MEDLINE","year":"2019","journal-title":"Library Medicine"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/pon.3962","article-title":"Depression and distress in caregivers of children with brain tumors undergoing treatment: psychosocial factors as moderators","volume":"25","author":"Choi","year":"2016","journal-title":"Psychooncology"},{"key":"ref1951","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/pbc.25955","article-title":"Guideline for the treatment of breakthrough and the prevention of refractory chemotherapy-induced nausea and vomiting in children with cancer","volume":"63","author":"Flank","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.3892\/ol.2016.5012","article-title":"Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions","volume":"12","author":"H\u00f6gfeldt","year":"2016","journal-title":"Oncol Lett"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08880018.2013.834400","article-title":"Pediatric Burkitt\u2019s lymphoma and diffuse B-cell lymphoma: are surveillance scans required?","volume":"31","author":"Eissa","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/pbc.21585","article-title":"The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: a retrospective analysis of enrolled cases in Japan","volume":"51","author":"Fujita","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"e7518","DOI":"10.1097\/MD.0000000000007518","article-title":"Silent presentation of multiple metastasis Burkitt lymphoma in a child: a case report and review of the literature","volume":"96","author":"Miron","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref511","article-title":"Intergroup randomized trial for children or adolescents with cell non Hodgkin lymphoma or acute leukemia : Rituximab evaluation in high risk patients Children Group Accessed Available at https clinicaltrials gov ct show","volume":"24","author":"Gustave Roussy","year":"2017","journal-title":"Cancer Campus Oncology"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1002\/cncr.27396","article-title":"Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab","volume":"118","author":"Akyurek","year":"2012","journal-title":"Cancer"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","article-title":"Burkitt\u2019s and Burkitt-like lymphoma in children and adolescents: a review of the Children\u2019s Cancer Group experience","volume":"120","author":"Cairo","year":"2003","journal-title":"Br J Haematol"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/pbc.24426","article-title":"Children\u2019s Oncology Group\u2019s 2013 blueprint for research: cancer control and supportive care","volume":"60","author":"Sung","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref2041","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N Engl J Med"},{"key":"ref1971","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/pon.3962","article-title":"Depression and distress in caregivers of children with brain tumors undergoing treatment: psychosocial factors as moderators","volume":"25","author":"Choi","year":"2016","journal-title":"Psychooncology"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5152\/dir.2015.15211","article-title":"Imaging features of Burkitt lymphoma in pediatric patients","volume":"22","author":"Derinkuyu","year":"2016","journal-title":"Diagn Interv Radiol"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1002\/cncr.30923","article-title":"Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States","volume":"123","author":"Yanik","year":"2017","journal-title":"Cancer"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1200\/JCO.1984.2.9.979","article-title":"High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas","volume":"2","author":"Hartmann","year":"1984","journal-title":"J Clin Oncol"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jamaoncol.2017.0368","article-title":"Patients\u2019 and parents\u2019 needs, attitudes, and perceptions about early palliative care integration in pediatric oncology","volume":"3","author":"Levine","year":"2017","journal-title":"JAMA Oncol"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"e184169","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjh.14812","article-title":"Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents","volume":"179","author":"Szczepanowski","year":"2017","journal-title":"Br J Haematol"},{"key":"ref1691","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MNM.0b013e328334fc14","article-title":"False-positive F-18 FDG uptake in PET\/CT studies in pediatric patients with abdominal Burkitt\u2019s lymphoma","volume":"31","author":"Riad","year":"2010","journal-title":"Nucl Med Commun"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/pbc.24722","article-title":"Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation","volume":"60","author":"Giulino-Roth","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/bjh.15491","article-title":"Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB\/LMB 96: A report from the FAB\/LMB 96 study group","volume":"182","author":"Cairo","year":"2018","journal-title":"Br J Haematol"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2008.005355","article-title":"Clinicopathological features of lymphoma\/leukemia patients carrying both BCL2 and MYC translocations","volume":"94","author":"Tomita","year":"2009","journal-title":"Haematologica"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pbc.21753","article-title":"A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent\/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"52","author":"Griffin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JOP.2014.001495","article-title":"Financial burden of pediatric cancer for patients and their families","volume":"11","author":"Warner","year":"2015","journal-title":"J Oncol Pract"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo","year":"2010","journal-title":"Br J Haematol"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"e27752","DOI":"10.1002\/pbc.27752","article-title":"Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe","volume":"66","author":"Vaillant","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"ref1941","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1200\/JCO.18.00407","article-title":"Guideline for the management of clostridium difficile infection in children and adolescents with cancer and pediatric hematopoietic stem-cell transplantation recipients","volume":"36","author":"Diorio","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref631","first-page":"148","article-title":"Interim PET response criteria in paediatric non-Hodgkin\u2019s lymphoma. Results from a retrospective multicenter reading","volume":"52","author":"Furth","year":"2013","journal-title":"Nucl Med (Stuttg)"},{"key":"ref1741","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4143\/crt.2013.047","article-title":"Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents","volume":"46","author":"Kim","year":"2014","journal-title":"Cancer Res Treat"},{"key":"ref1831","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbmt.2009.09.021","article-title":"Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents","volume":"16","author":"Gross","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref1871","doi-asserted-by":"crossref","first-page":"157","DOI":"10.21037\/apm.2016.04.03","article-title":"Child\u2019s symptom burden and depressive symptoms among caregivers of children with cancers: an argument for early integration of pediatric palliative care","volume":"5","author":"Olagunju","year":"2016","journal-title":"Ann Palliat Med"},{"key":"ref1881","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/pbc.24426","article-title":"Children\u2019s Oncology Group\u2019s 2013 blueprint for research: cancer control and supportive care","volume":"60","author":"Sung","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"key":"ref1891","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/pbc.23039","article-title":"Neuropathic pain during treatment for childhood acute lymphoblastic leukemia","volume":"57","author":"Anghelescu","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"ref1171","article-title":"Burkitt Lymphoma","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","volume":"Vol. 2","author":"Swerdlow","year":"2017"},{"key":"ref461","author":"Genentech, Inc","year":"2019","journal-title":"RITUXAN\u00ae (rituximab) injection, for intravenous use"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2012.255","article-title":"Rituximab and FAB\/LMB 96 chemotherapy in children with Stage III\/IV B-cell non-Hodgkin lymphoma: a Children\u2019s Oncology Group report","volume":"27","author":"Goldman","year":"2013","journal-title":"Leukemia"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/gcc.22161","article-title":"Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples","volume":"53","author":"Maria Murga Penas","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"ref1561","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2012.255","article-title":"Rituximab and FAB\/LMB 96 chemotherapy in children with Stage III\/IV B-cell non-Hodgkin lymphoma: a Children\u2019s Oncology Group report","volume":"27","author":"Goldman","year":"2013","journal-title":"Leukemia"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3324\/haematol.2010.026831","article-title":"Detection of genomic aberrations in molecularly defined Burkitt\u2019s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis","volume":"95","author":"Scholtysik","year":"2010","journal-title":"Haematologica"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.13501","article-title":"Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations","volume":"170","author":"Aukema","year":"2015","journal-title":"Br J Haematol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1002\/cncr.30923","article-title":"Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States","volume":"123","author":"Yanik","year":"2017","journal-title":"Cancer"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.beha.2018.07.013","article-title":"Burkitt lymphoma- a rare but challenging lymphoma","volume":"31","author":"Casulo","year":"2018","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref1471","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","article-title":"Revised international pediatric non-Hodgkin lymphoma staging system","volume":"33","author":"Rosolen","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref1531","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1200\/JCO.18.00407","article-title":"Guideline for the management of clostridium difficile infection in children and adolescents with cancer and pediatric hematopoietic stem-cell transplantation recipients","volume":"36","author":"Diorio","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref2071","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo","year":"2010","journal-title":"Br J Haematol"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"key":"ref541","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-M\u00fcnster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1200\/JCO.2014.59.0745","article-title":"International pediatric non-Hodgkin lymphoma response criteria","volume":"33","author":"Sandlund","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1200\/JCO.2007.11.0700","article-title":"Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin\u2019s lymphoma differ by non-Hodgkin\u2019s lymphoma subtype: a Berlin-Frankfurt-Munster Group Report","volume":"25","author":"Salzburg","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","article-title":"Treatment of children and young adults with early-stage non-Hodgkin\u2019s lymphoma","volume":"337","author":"Link","year":"1997","journal-title":"N Engl J Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2017-11-817601","article-title":"Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma","volume":"131","author":"Ren","year":"2018","journal-title":"Blood"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"e7089","DOI":"10.1371\/journal.pone.0007089","article-title":"High resolution genome-wide analysis of chromosomal alterations in Burkitt\u2019s lymphoma","volume":"4","author":"Toujani","year":"2009","journal-title":"PLoS One"},{"key":"ref1751","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1200\/JCO.1984.2.9.979","article-title":"High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas","volume":"2","author":"Hartmann","year":"1984","journal-title":"J Clin Oncol"},{"key":"ref1981","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JOP.2014.001495","article-title":"Financial burden of pediatric cancer for patients and their families","volume":"11","author":"Warner","year":"2015","journal-title":"J Oncol Pract"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cjp2.10","article-title":"The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit","volume":"1","author":"Clipson","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/QCO.0b013e328349ac4f","article-title":"The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma","volume":"24","author":"Moormann","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","article-title":"Burkitt\u2019s and Burkitt-like lymphoma in children and adolescents: a review of the Children\u2019s Cancer Group experience","volume":"120","author":"Cairo","year":"2003","journal-title":"Br J Haematol"},{"key":"ref1721","doi-asserted-by":"crossref","first-page":"e27873","DOI":"10.1002\/pbc.27873","article-title":"Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study","volume":"66","author":"Rigaud","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3324\/haematol.2010.026831","article-title":"Detection of genomic aberrations in molecularly defined Burkitt\u2019s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis","volume":"95","author":"Scholtysik","year":"2010","journal-title":"Haematologica"},{"key":"ref1461","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol"},{"key":"ref1931","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S2352-4642(18)30059-2","article-title":"Management of fatigue in children and adolescents with cancer and in paediatric recipients of haemopoietic stem-cell transplants: a clinical practice guideline","volume":"2","author":"Robinson","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"ref1361","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.13501","article-title":"Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations","volume":"170","author":"Aukema","year":"2015","journal-title":"Br J Haematol"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"e7518","DOI":"10.1097\/MD.0000000000007518","article-title":"Silent presentation of multiple metastasis Burkitt lymphoma in a child: a case report and review of the literature","volume":"96","author":"Miron","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref1901","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref1111","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.3892\/ol.2016.5012","article-title":"Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions","volume":"12","author":"H\u00f6gfeldt","year":"2016","journal-title":"Oncol Lett"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"157","DOI":"10.21037\/apm.2016.04.03","article-title":"Child\u2019s symptom burden and depressive symptoms among caregivers of children with cancers: an argument for early integration of pediatric palliative care","volume":"5","author":"Olagunju","year":"2016","journal-title":"Ann Palliat Med"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3109\/10428194.2012.677534","article-title":"Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia","volume":"53","author":"Anoop","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"ref2011","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5152\/dir.2015.15211","article-title":"Imaging features of Burkitt lymphoma in pediatric patients","volume":"22","author":"Derinkuyu","year":"2016","journal-title":"Diagn Interv Radiol"},{"key":"ref2051","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.12542","article-title":"Rasburicase in the prevention of laboratory\/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children\u2019s Oncology Group Report","volume":"163","author":"Galardy","year":"2013","journal-title":"Br J Haematol"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bjh.13219","article-title":"The role of FDG-PET\/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma","volume":"168","author":"Bhojwani","year":"2015","journal-title":"Br J Haematol"},{"key":"ref2061","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","article-title":"Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement","volume":"28","author":"Pienkowska-Grela","year":"2011","journal-title":"Med Oncol"},{"key":"ref1551","article-title":"Intergroup randomized trial for children or adolescents with cell non Hodgkin lymphoma or acute leukemia : Rituximab evaluation in high risk patients Children Group Accessed Available at https clinicaltrials gov ct show","volume":"24","author":"Gustave Roussy","year":"2017","journal-title":"Cancer Campus Oncology"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"e1008027","DOI":"10.1371\/journal.pgen.1008027","article-title":"Genetic signatures of gene flow and malaria-driven natural selection in sub-Saharan populations of the \u201cendemic Burkitt Lymphoma belt","volume":"15","author":"Gouveia","year":"2019","journal-title":"PLoS Genet"},{"key":"ref2031","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12325-011-0041-1","article-title":"Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel","volume":"28","author":"Pession","year":"2011","journal-title":"Adv Ther"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3109\/10428194.2012.677534","article-title":"Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia","volume":"53","author":"Anoop","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/pbc.23039","article-title":"Neuropathic pain during treatment for childhood acute lymphoblastic leukemia","volume":"57","author":"Anghelescu","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/bloodadvances.2018026203","article-title":"Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients","volume":"3","author":"Naik","year":"2019","journal-title":"Blood Adv"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","article-title":"Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin\u2019s lymphoma: results of the FAB\/LMB 96 international study","volume":"141","author":"Gerrard","year":"2008","journal-title":"Br J Haematol"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/18\/8\/article-p1105.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/18\/8\/article-p1105.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T18:29:32Z","timestamp":1602872972000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/18\/8\/article-p1105.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":204,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2020.0036","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}